Jazz Pharmaceuticals (JAZZ) Raw Materials (2010 - 2019)

Jazz Pharmaceuticals' Raw Materials history runs 10 years deep, the most recent figure standing at $7.1 million for Q1 2019.

• On a quarterly basis, Raw Materials changed N/A year-over-year to $7.1 million in Q1 2019; TTM through Mar 2019 was $7.1 million, a N/A change from a year earlier, with the FY2018 full-year figure at $5.6 million, up 58.22% from the prior year.
• Raw Materials climbed to $7.1 million in Q1 2019 per JAZZ's latest filing, from $5.6 million in the prior quarter.
• Across five years, Raw Materials topped out at $7.1 million in Q1 2019 and bottomed at $1.5 million in Q4 2016.
• The 5-year median for Raw Materials is $2.7 million (2016), against an average of $3.6 million.
• Across the five-year window, Raw Materials slumped 40.68% in 2016 and surged 128.96% in 2017, its largest moves.
• Year by year, Raw Materials stood at $2.6 million in 2015, then slumped by 40.68% to $1.5 million in 2016, then soared by 128.96% to $3.5 million in 2017, then surged by 58.22% to $5.6 million in 2018, then advanced by 27.37% to $7.1 million in 2019.
• Per Business Quant, the three latest JAZZ Raw Materials figures stand at $7.1 million (Q1 2019), $5.6 million (Q4 2018), and $4.2 million (Q2 2018).